A ATRICURE INC
| Market Cap | $1.45B |
| P/E Ratio | — |
| Forward P/E | 78.65 |
| Dividend Yield | — |
| Beta | 1.43 |
| 52W Range | $28.26 - $42.41 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 0.01% | $4.61M | 116,609 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 9 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Doraiswamy VinayakChief Scientific Officer | Sale | 5,000 | $29.83 | $149.15K | 12 Mar 2026 | 12 Mar 2026 |
| Noznesky Justin JChief Mktg & Strategy Officer | Sale | 5,166 | $37.29 | $192.64K | 26 Nov 2025 | 26 Nov 2025 |
| Justin J NozneskyChief Mktg & Strategy Officer | Sale | 5,166 | $37.29 | $192.64K | 26 Nov 2025 | 26 Nov 2025 |
| WEHRWEIN SVEN | Sale | 4,967 | $38.00 | $188.75K | 25 Nov 2025 | 26 Nov 2025 |
| Sven WehrweinDirector | Sale | 4,967 | $38.00 | $188.75K | 25 Nov 2025 | 26 Nov 2025 |
| WEHRWEIN SVEN | Sale | 5,033 | $37.32 | $187.83K | 24 Nov 2025 | 26 Nov 2025 |
| Sven WehrweinDirector | Sale | 5,033 | $37.32 | $187.83K | 24 Nov 2025 | 26 Nov 2025 |
| Yuen Maggie | Sale | 3,000 | $35.72 | $107.16K | 21 Nov 2025 | 25 Nov 2025 |
| Maggie YuenDirector | Sale | 3,000 | $35.72 | $107.16K | 21 Nov 2025 | 25 Nov 2025 |
Frequently Asked Questions
What is ATRC stock price today?
ATRICURE INC (ATRC) is currently trading at $29.07. The stock has a 52-week range of $28.26 to $42.41 and a market capitalization of $1.45B.
Is ATRC a good stock to buy in 2026?
ATRICURE INC has a P/E ratio of N/A (forward P/E: 78.7), a dividend yield of none, and 1-year performance of -11.7%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ATRC stock?
There have been 9 insider transactions for ATRC in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ATRC stock performed over the past year?
ATRICURE INC (ATRC) has returned -11.7% over the past 12 months. The stock traded between $28.26 and $42.41 during this period, and is currently at $29.07.
Which hedge funds own ATRC (ATRICURE INC)?
1 tracked hedge funds currently hold ATRC in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ATRC's market cap and valuation?
ATRICURE INC (ATRC) has a market capitalization of $1.45B. The trailing P/E ratio is N/A and forward P/E is 78.7. The stock is classified in the Healthcare sector.
What is ATRC's revenue and profitability?
ATRICURE INC reported revenue of $534.53M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.43.
What sector is ATRC in and who are its biggest institutional holders?
ATRICURE INC (ATRC) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.